EUVIMEDObjevte EUVIMED
Crossref

Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation

Wen Shao, Yuanyuan Liu, Deling Jiang, Zhiyang Xing, Jiale Qiao, Man Liu, Xupeng Huang, Renyu Zhang, Yuying Fang iD, Wei Peng

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500487 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Wen Shao and 9 co-authors. Institution: Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First A…. Major MEDLINE topics: Ferroptosis, Indoles, Antioxidants. 36 references. Funded by: The Guangdong Basic and Applied Basic Research Foundation, The National Natural Science Foundation of China, The China Postdoctoral Science Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Ferroptosis, a form of regulated cell death characterized by excessive lipid peroxidation, has been implicated in various neurological disorders. Ferrostatin‐1 (Fer‐1), a well‐known ferroptosis inhibitor, exhibits therapeutic potential but suffers from poor metabolic stability, limiting its applications. In this study, a phenotype‐based screening of an in‐house compound library is conducted and a novel ferroptosis inhibitor, TJC‐2‐1 , is identified. To optimize its inhibitory activity, a series of 35 indoline derivatives are synthesized and evaluated. Among them, compound 14 exhibits the most potent inhibition against erastin‐induced (EC 50 = 0.15 μM) and RSL3‐induced (EC 50 = 0.15 μM) ferroptosis in HT22 mouse hippocampal cells. Mechanistic investigations reveal that compound 14 functions as a novel radical‐trapping antioxidant, exhibiting lipid peroxidation scavenging capacity comparable to that of Fer‐1. Remarkably, compound 14 demonstrates significantly improved microsomal metabolic stability compared to Fer‐1. These findings suggest that compound 14 has the potential to serve as a lead compound for ferroptosis‐related diseases.

Subjects

MeSH terms (MEDLINE)

FerroptosisIndolesAntioxidantsAnimalsMiceStructure-Activity RelationshipMolecular StructureLipid PeroxidationDose-Response Relationship, DrugCell LinePiperazinesPhenylenediaminesCyclohexylamines

Author keywords

ferroptosis inhibitorindoline derivativesneurological diseasesradical‐trapping antioxidant

Substances

IndolesindolinePiperazinesferrostatin-1AntioxidantsPhenylenediaminesCyclohexylamines

Authors and institutions

  • Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, C…
  • University of South China, Hengyang, 421001, China.
  • Innovative Center for Pathogen Research, Guangzhou National Laboratory, Guangzhou, 510005, China.

ORCID profiles: Yuying Fang

Funding

  • The Guangdong Basic and Applied Basic Research Foundation
  • The National Natural Science Foundation of China
  • The China Postdoctoral Science Foundation
  • The R&D Program of Guangzhou National Laboratory

Cite

APA

Shao, W., Liu, Y., Jiang, D., Xing, Z., Qiao, J., Liu, M., Huang, X., Zhang, R., Fang, Y., & Peng, W. (2025). Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. https://doi.org/10.1002/cmdc.202500487

Vancouver

Shao W, Liu Y, Jiang D, Xing Z, Qiao J, Liu M, et al. Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. 2025. doi:10.1002/cmdc.202500487

BibTeX
@article{Shao2025,
  author = {Shao, Wen and Liu, Yuanyuan and Jiang, Deling and Xing, Zhiyang and Qiao, Jiale and Liu, Man and Huang, Xupeng and Zhang, Renyu and Fang, Yuying and Peng, Wei},
  title = {Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500487}
}
Start for free →